We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+12.02%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$64.6B
AUM Growth
+$5.95B
Cap. Flow
+$299M
Cap. Flow %
0.46%
Top 10 Hldgs %
11.91%
Holding
4,318
New
702
Increased
1,590
Reduced
1,355
Closed
633

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$653M
2
AMZN icon
Amazon
AMZN
+$602M
3
XOM icon
ExxonMobil
XOM
+$473M
4
TSLA icon
Tesla
TSLA
+$437M
5
SBUX icon
Starbucks
SBUX
+$380M

Sector Composition

Rank Sector Weight
1 Technology 19.68%
2 Healthcare 17.69%
3 Consumer Discretionary 13.09%
4 Industrials 7.96%
5 Consumer Staples 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADIL
3476
Adial Pharmaceuticals
ADIL
$10.5M
$43K ﹤0.01%
+928
New +$50.9K
PERF icon
3477
Perfect Corp
PERF
$196M
$43K ﹤0.01%
+14,000
New +$39.2K
SABS icon
3478
SAB Biotherapeutics
SABS
$294M
$43K ﹤0.01%
6,310
+500
+9% +$4.19K
ABVC icon
3479
ABVC BioPharma
ABVC
$26.5M
$42K ﹤0.01%
+36,100
New +$42.6K
LIQT icon
3480
LiqTech
LIQT
$20.1M
$42K ﹤0.01%
12,228
-7,242
-37% -$25.9K
NSPR icon
3481
InspireMD
NSPR
$33.8M
$42K ﹤0.01%
15,000
-1,700
-10% -$4.89K
OTLK icon
3482
Outlook Therapeutics
OTLK
$182M
$42K ﹤0.01%
+5,271
New +$44.6K
SOL
3483
DELISTED
Emeren Group
SOL
$42K ﹤0.01%
15,400
-9,240
-38% -$24.4K
NBSE
3484
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$42K ﹤0.01%
+56,967
New +$41.6K
FNCH
3485
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$42K ﹤0.01%
+11,746
New +$46.3K
DPRO
3486
Draganfly
DPRO
$164M
$41K ﹤0.01%
+3,441
New +$51.5K
RBBN icon
3487
Ribbon Communications
RBBN
$376M
$41K ﹤0.01%
14,000
-17,600
-56% -$39.7K
NXTP
3488
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
$41K ﹤0.01%
+17,735
New +$14.9K
SALM
3489
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$41K ﹤0.01%
106,100
+1,900
+2% +$1.2K
LABP
3490
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$41K ﹤0.01%
11,260
+1,000
+10% +$3.94K
AMTD
3491
AMTD IDEA Group
AMTD
$71.5M
$40K ﹤0.01%
+22,333
New +$52.9K
BRCC icon
3492
BRC Inc
BRCC
$241M
$40K ﹤0.01%
+11,036
New +$38K
IDAI icon
3493
T Stamp
IDAI
$17.5M
$40K ﹤0.01%
+1,947
New +$41.6K
SANW
3494
DELISTED
S&W Seed Co
SANW
$40K ﹤0.01%
2,984
+299
+11% +$3.84K
BGMS
3495
Bio Green Med Solution Inc
BGMS
$5.35M
$39K ﹤0.01%
60
+8
+15% +$11.5K
HYFT
3496
MindWalk Holdings
HYFT
$60.1M
$39K ﹤0.01%
23,000
+8,400
+58% +$12.5K
SGRP
3497
DELISTED
SPAR Group
SGRP
$39K ﹤0.01%
39,000
+1,800
+5% +$1.72K
VBIV
3498
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$39K ﹤0.01%
66,842
+39,500
+144% +$23.8K
EVGN icon
3499
Evogene
EVGN
$8.29M
$38K ﹤0.01%
4,480
-60
-1% -$377
ALP
3500
Alpha Compute
ALP
$4.29M
$38K ﹤0.01%
1,055
+355
+51% +$11.8K

Similar funds

Renaissance Technologies's Q4 2023 Portfolio in Review

As of Q4 2023, Renaissance Technologies held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Renaissance Technologies's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
  • Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
  • Renaissance Technologies's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
  • Renaissance Technologies fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
  • Renaissance Technologies opened 702 new positions and closed 633 in Q4 2023.
  • Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $64.6B.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.